Targets › UL30
1 program from 1 company in 1 trial: 1 Phase 4; Infectious disease.
Open in Phaseline: the race on UL30, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| University of Guadalajara | Valganciclovir Human herpesvirus 1 DNA polymerase inhibitor | UL30 | Phase 4 | Cytomegalovirus Infections | – |
Cytomegalovirus Infections (1)
small molecule (1)
University of Guadalajara (1)
–
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.